Beschreibung

Study design for the randomized trial evaluating a curcuma longa and boswellia serrata formulation combined with low-FODMAP diet for abdominal bloating in IBS patients.

Figure 1

Flowchart

Source Paper

Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with …

Nutrients (2022)

PMID: 35276778

DOI: 10.3390/nu14030416

Cite This Figure

![Figure 1: Study design for the randomized trial evaluating a curcuma longa and boswellia serrata formulation combined with low-FODMAP diet for abdominal bloating in IBS patients.]()

> Source: Attilio Giacosa et al. "Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulati." *Nutrients*, 2022. PMID: [35276778](https://pubmed.ncbi.nlm.nih.gov/35276778/)

<figure>
  <img src="" alt="Study design for the randomized trial evaluating a curcuma longa and boswellia serrata formulation combined with low-FODMAP diet for abdominal bloating in IBS patients." />
  <figcaption>Figure 1. Study design for the randomized trial evaluating a curcuma longa and boswellia serrata formulation combined with low-FODMAP diet for abdominal bloating in IBS patients.<br>  Source: Attilio Giacosa et al. "Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulati." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35276778/">35276778</a></figcaption>
</figure>

Beschreibung

Figure 1

Source Paper

Cite This Figure

Verwandte Evidenz